Acorda to buy Civitas Therapeutics for $525 million

September 24, 2014 1:01 PM

12 0

The deal effectively ends Civitas’s plans to go public

Acorda Therapeutics Inc. said Wednesday that it has agreed to buy fellow neurological drug maker Civitas Therapeutics for $525 million in cash, effectively putting an end to Civitas’s plans to go public.

Also read: Chinese Online Lender LexinFintech Shrinks U.S. IPO Fundraising Goal

Read more

To category page